Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Barrett's esophagus: a molecular perspective.

Stuart Jon Spechler1

  • 1Division of Gastroenterology, Dallas VA Medical Center, 4500 South Lancaster Road, Dallas, TX 75216, USA. sjspechler@aol.com

Current Gastroenterology Reports
|May 26, 2005
PubMed
Summary

Barrett

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The protease inhibitor darunavir prevents esophagitis and impairments in esophageal barrier function in a mouse model of GERD.

American journal of physiology. Gastrointestinal and liver physiology·2026
Same author

In Obesity, Esophagogastric Junction Fat Impairs Esophageal Barrier Function and Dilates Intercellular Spaces via Hypoxia-Inducible Factor 2α.

Gastroenterology·2024
Same author

Hypoxia-inducible factor-1α mediates reflux-induced epithelial-mesenchymal plasticity in Barrett's oesophagus patients.

Gut·2024
Same author

Th2 cytokine signaling through IL-4Rα increases eotaxin-3 secretion and tension in human esophageal smooth muscle.

American journal of physiology. Gastrointestinal and liver physiology·2023
Same author

Why Has Screening and Surveillance for Barrett's Esophagus Fallen Short in Stemming the Rising Incidence of Esophageal Adenocarcinoma?

The American journal of gastroenterology·2023
Same author

Response to Haseeb et al.

The American journal of gastroenterology·2022

Area of Science:

  • Gastroenterology and Molecular Oncology.

Background:

  • Barrett's esophagus is a precursor to esophageal adenocarcinoma.
  • Carcinogenesis involves the accumulation of genetic abnormalities.
  • Gastroesophageal reflux may trigger molecular changes.

Purpose of the Study:

  • To review molecular abnormalities in Barrett's esophagus.
  • To understand the hallmarks of malignancy acquisition.
  • To discuss the role of specific genes in carcinogenesis.

Main Methods:

  • Review of recent scientific publications.
  • Analysis of molecular pathways involved in cancer development.
  • Examination of genetic alterations in Barrett's esophagus.

Main Results:

  • Gastroesophageal reflux activates pathways promoting proliferation and inhibiting apoptosis.
  • Inactivation of p16 and p53 tumor suppressor genes is crucial.
  • Mechanisms include promoter methylation, gene mutation, and loss of heterozygosity.

Conclusions:

  • Molecular abnormalities in Barrett's esophagus drive cancer hallmarks.
  • p16 and p53 gene inactivation are key events.
  • The Cdx2 gene plays a role in esophageal intestinal metaplasia development.

Related Experiment Videos